Biologic Drug Discovery with AI: Luke Timmerman’s Long Run Podcast Interviews Absci’s Sean McClain

One of the key questions five years ago was how to feed AI with relevant data sets from wet labs, so it would have quality data that’s the essential grist for machines to learn from. Absci embraced the new tool with an eye toward using it to speed up discovery of biologics drug candidates.